Authors:
Lawrence, D
Shahrokh, Z
Marsters, S
Achilles, K
Shih, D
Mounho, B
Hillan, K
Totpal, K
DeForge, L
Schow, P
Hooley, J
Sherwood, S
Pai, R
Leung, S
Khan, LL
Gliniak, B
Bussiere, J
Smith, CA
Strom, SS
Kelley, S
Fox, JA
Thomas, D
Ashkenazi, A
Citation: D. Lawrence et al., Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions, NAT MED, 7(4), 2001, pp. 383-385
Authors:
Kelley, SK
Harris, LA
Xie, D
Deforge, L
Totpal, K
Bussiere, J
Fox, JA
Citation: Sk. Kelley et al., Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety, J PHARM EXP, 299(1), 2001, pp. 31-38
Authors:
Shields, RL
Namenuk, AK
Hong, K
Meng, YG
Rae, J
Briggs, J
Xie, D
Lai, J
Stadlen, A
Li, B
Fox, JA
Presta, LG
Citation: Rl. Shields et al., High resolution mapping of the binding site on human IgG1 for Fc gamma RI,Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R, J BIOL CHEM, 276(9), 2001, pp. 6591-6604
Authors:
Kallmeyer, IJ
Collard, CD
Fox, JA
Body, SC
Shernan, SK
Citation: Ij. Kallmeyer et al., The safety of intraoperative transesophageal echocardiography: A case series of 7200 cardiac surgical patients, ANESTH ANAL, 92(5), 2001, pp. 1126-1130
Authors:
Kohne, C
Johnson, A
Tom, S
Peers, DH
Gehant, RL
Hotaling, TA
Brousseau, D
Ryll, T
Fox, JA
Chamow, SM
Berman, PW
Citation: C. Kohne et al., Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator, J CELL BIOC, 75(3), 1999, pp. 446-461
Authors:
Sliwkowski, MX
Lofgren, JA
Lewis, GD
Hotaling, TE
Fendly, BM
Fox, JA
Citation: Mx. Sliwkowski et al., Nonclinical studies addressing the mechanism of action of trastuzumab (herceptin), SEMIN ONCOL, 26(4), 1999, pp. 60-70